Video Experimental Relacionado
Updated: Jun 23, 2026
06:51
Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
Un programa de senescencia controlado por p53 y p16INK4a contribuye al resultado de la terapia contra el cáncer
Clemens A Schmitt1, Jordan S Fridman, Meng Yang
1Cold Spring Harbor Laboratory, 1 Bungtown Road, New York 11724, USA.
Cell
|May 23, 2002
Resumen
La senescencia celular, controlada por p53 y p16 (INK4a), tiene un impacto en la respuesta a la quimioterapia en los linfomas. Los tumores con defectos de senescencia muestran malos resultados, destacando la senescencia.
Área de la Ciencia:
- Oncología Oncología.
- Biología celular Biología celular.
- Investigación de Investigación del Cáncer.
Sus antecedentes:
- Las mutaciones en p53 e INK4a / ARF están relacionadas con la tumorigénesis y la resistencia a los medicamentos al inhibir la apoptosis.
- La senescencia celular es un mecanismo supresor de tumores clave.
Objetivo del estudio:
- Para investigar el papel de la senescencia celular en la respuesta del linfoma a la quimioterapia.
- Para determinar el impacto de las mutaciones p53 e INK4a/ARF en la eficacia de la quimioterapia in vivo.
Principales métodos:
- Tratamiento de los linfomas murinos primarios con ciclofosfamida.
- Análisis de p53, p16 (INK4a) y marcadores de senescencia.
- Evaluación de la respuesta tumoral y pronóstico en ratones.
Principales resultados:
- Los tumores con mutaciones p53 o INK4a/ARF respondieron mal a la ciclofosfamida.
- La citostasis inducida por fármacos que involucra marcadores de senescencia se observó en tumores con un bloqueo apoptótico.
- La adquisición de mutaciones p53 o INK4a se produjo tras la progresión en los tumores tratados con fármacos.
- Los tumores capaces de senescencia inducida por fármacos se correlacionan con un mejor pronóstico.
Conclusiones:
- La senescencia celular, regulada por p53 y p16 (INK4a), es un determinante crítico del resultado de la quimioterapia en los linfomas.
- Los defectos de senescencia en los tumores conducen a una mala respuesta a la quimioterapia.
- Dirigirse o preservar las vías de senescencia puede mejorar las estrategias de tratamiento del cáncer.
Más Videos Relacionados
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
08:56Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
Videos de Conceptos Relacionados
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...